Research Article
Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants
Figure 3
One-way MLR demonstrating significant donor-specific hyporesponsiveness conferred by seven consecutive daily intrajejunal doses of LBN FDS. “*” ; “NS” .